Terms: = Brain cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Diagnosis
156 results:
1. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
[TBL] [Abstract] [Full Text] [Related]
2. Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults.
Hébert J; De Santis RJ; Daniyal L; Mannan S; Ng E; Thain E; Sanabria-Salas MC; Kim RH; Bril V; Reid AY
Epilepsy Res; 2024 May; 202():107336. PubMed ID: 38471245
[TBL] [Abstract] [Full Text] [Related]
3. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
Patrizi S; Miele E; Falcone L; Vallese S; Rossi S; Barresi S; Giovannoni I; Pedace L; Nardini C; Masier I; Abballe L; Cacchione A; Russo I; Di Giannatale A; Di Ruscio V; Salgado CM; Mastronuzzi A; Ciolfi A; Tartaglia M; Milano GM; Locatelli F; Alaggio R
Clin Epigenetics; 2024 Jan; 16(1):9. PubMed ID: 38178234
[TBL] [Abstract] [Full Text] [Related]
4. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
5. Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency.
Guerrini-Rousseau L; Pasmant E; Muleris M; Abbou S; Adam-De-Beaumais T; Brugieres L; Cabaret O; Colas C; Cotteret S; Decq P; Dufour C; Guillerm E; Rouleau E; Varlet P; Zili S; Vidaud D; Grill J
J Med Genet; 2024 Jan; 61(2):158-162. PubMed ID: 37775264
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Features of Resected Melanoma brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
[TBL] [Abstract] [Full Text] [Related]
8. Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis-a case report.
Ogasawara N; Yamashita S; Yamasaki K; Kawano T; Kawano T; Muta J; Matsumoto F; Watanabe T; Ohta H; Yokogami K; Fukushima T; Sato Y; Takeshima H
Brain Tumor Pathol; 2023 Oct; 40(4):222-229. PubMed ID: 37515639
[TBL] [Abstract] [Full Text] [Related]
9. Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.
Weiß S; Thomale UW; Schulz M; Kandels D; Schuhmann MU; El Damaty A; Krauss J; Driever PH; Witt O; Bison B; Pietsch T; Gnekow A; Simon M
Int J Cancer; 2023 Oct; 153(8):1487-1500. PubMed ID: 37260252
[TBL] [Abstract] [Full Text] [Related]
10. Basement membrane proteins in extracellular matrix characterize nf1 neurofibroma development and response to MEK inhibitor.
Jiang C; Kumar A; Yu Z; Shipman T; Wang Y; McKay RM; Xing C; Le LQ
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37140985
[TBL] [Abstract] [Full Text] [Related]
11. Constitutional Mismatch Repair Deficiency Syndromes, a Neurofibromatosis 1 Mimicker That Hinders Timely Management.
Mir A; AlMudhry M; AlOtaibi W; AlHazmi R; AlBaradie R; AlHarbi Q; Bashir S; Chamdine O; Housawi Y
J Pediatr Hematol Oncol; 2023 Jul; 45(5):e613-e620. PubMed ID: 36897649
[TBL] [Abstract] [Full Text] [Related]
12. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
[TBL] [Abstract] [Full Text] [Related]
13. Malignant peripheral nerve sheath tumours in a patient with Neurofibromatosis-1.
Iqbal F; Jamaluddin M; Bukhari F; Islam OS
J Pak Med Assoc; 2023 Feb; 73(2):393-395. PubMed ID: 36800734
[TBL] [Abstract] [Full Text] [Related]
14. Lymphomas in patients with neurofibromatosis type 1 (nf1): another malignancy in the nf1 syndrome?
Fareez F; Wang BH; Brain I; Lu JQ
Pathology; 2023 Apr; 55(3):302-314. PubMed ID: 36774237
[TBL] [Abstract] [Full Text] [Related]
15. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
[TBL] [Abstract] [Full Text] [Related]
16. All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant.
Wolf T; Coca AH; Weingertner N; Chenard MP; Meurgey A; Reita D; Pencreach E; Varlet P; Entz-Werlé N; Lhermitte B
Virchows Arch; 2023 Feb; 482(2):431-435. PubMed ID: 36307659
[TBL] [Abstract] [Full Text] [Related]
17. Nervous system (NS) Tumors in cancer Predisposition Syndromes.
Patil P; Pencheva BB; Patil VM; Fangusaro J
Neurotherapeutics; 2022 Oct; 19(6):1752-1771. PubMed ID: 36056180
[TBL] [Abstract] [Full Text] [Related]
18. [Lisch nodules: an ophthalmic marker of neurofibromatosis type 1].
Bouirig K; Cherkaoui LO
Pan Afr Med J; 2022; 42():108. PubMed ID: 36034030
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel.
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Fujio S; Kirishima M; Takigawa K; Hata N; Toh K; Yamamoto J; Hanaya R; Tanimoto A; Yoshimoto K
Neurol Med Chir (Tokyo); 2022 Sep; 62(9):391-399. PubMed ID: 36031351
[TBL] [Abstract] [Full Text] [Related]
20. Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort.
Foss-Skiftesvik J; Stoltze UK; van Overeem Hansen T; Ahlborn LB; Sørensen E; Ostrowski SR; Kullegaard SMA; Laspiur AO; Melchior LC; Scheie D; Kristensen BW; Skjøth-Rasmussen J; Schmiegelow K; Wadt K; Mathiasen R
Acta Neuropathol Commun; 2022 Aug; 10(1):123. PubMed ID: 36008825
[TBL] [Abstract] [Full Text] [Related]
[Next]
